BrightSpire Capital, Inc. Class A Common Stock (BRSP)

Ares Commercial Real Estate Corporation (NYSE: ACRE) is navigating a turbulent financial landscape, with recent reports revealing a significant contraction in its margin trends. The commercial real estate lender has seen its net interest margin (NIM) nearly halved year-over-year, alongside deeply negative operating and net profit margins. These immediate financial

BrightSpire Capital (BRSP) reported mixed Q2 2025 results, beating earnings estimates but missing revenue. Shares rose 2.2% as dividend coverage and risk reduction boosted investor confidence.

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million.

BRSP stock results show that BrightSpire Capital met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

BRSP stock results show that BrightSpire Capital beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday.

Bank of America has downgraded six Commercial Real Estate mortgage REITs. Here's why.

The latest data from the Mortgage Bankers Association (MBA) revealed a significant uptick in U.S. mortgage applications.

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.

Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually the highest among the total REIT universe.

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.